SCHEMBL23635804

SCHEMBL23635804

CC(C)OC(=O)c1sc2cccc(Cl)c2c1COc1ccc(C(N)=O)c(Br)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STING1 Q86WV6 7/20 0.64
MCL1 Q07820 3/20 0.40
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PARP15 Q460N3 3/20 0.39
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
PARP10 Q53GL7 2/20 0.36
TP53 P04637 1/20 0.36
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23111980 0.88 STING1 (0.65) STING1MCL1KDM4EALDH1A1MAPK1
SCHEMBL23111988 0.87 STING1 (0.79) STING1MCL1MAPK1PARP15
SCHEMBL30765111 0.87 STING1 (0.79) STING1MCL1MAPK1PARP15
SCHEMBL23635902 0.79 STING1 (0.80) STING1MCL1KDM4EALDH1A1MAPK1
SCHEMBL23630799 0.78 STING1 (1.00) STING1MCL1MAPK1PARP15PARP10
SCHEMBL30697680 0.78 STING1 (0.62) STING1MCL1KDM4EALDH1A1MAPK1
SCHEMBL23635887 0.78 STING1 (0.62) STING1MCL1KDM4EALDH1A1MAPK1
SCHEMBL23112029 0.76 STING1 (0.63) STING1MCL1KDM4EALDH1A1MAPK1
SCHEMBL26780397 0.76 KDM4E (0.52) STING1MCL1KDM4EALDH1A1MAPK1
SCHEMBL23635813 0.76 STING1 (0.76) STING1MCL1MAPK1PARP15PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-07-20 US disclosed
US-20210214333-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD. (AU) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227423-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 STING1 1/4885MCL1 1773/4885KDM4E 1469/4885
US-20210214333-A1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING STING1, CGAS, IRF3 STING1 1/4885MCL1 1851/4885KDM4E 1519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.